BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02961881-completion@plaintrial.com
DTSTAMP:20261028T052835Z
DTSTART;VALUE=DATE:20210902
SUMMARY:A Phase 1b Open-Label Study Investigating the Safety and Pharmacoki
 netics of Administration of Subcutaneous Blinatumomab for the Treatment of
  Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma — estimated complet
 ion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02961881
URL:https://plaintrial.com/trial/NCT02961881
END:VEVENT
END:VCALENDAR